Stocks

The table gives an overview of all stocks, alphabetically sorted.
 C Security CSEC Oct 29, 2020 0.25 -6.67   
 C-RAD B CRADB Oct 29, 2020 34.90 +1.01   
 CAG Group CAG Oct 29, 2020 60.60 0.00   
 Calliditas Therapeutics CALTX Oct 29, 2020 104.80 -2.42   
 Calmark B CALMAB Oct 29, 2020 4.83 +2.33   
 Camurus CAMX Oct 29, 2020 182.80 +2.70   
 Cantargia CANTA Oct 29, 2020 56.00 +1.08   
 Capacent Holding CAPAC Oct 29, 2020 33.00 +0.92   
 Carbiotix CRBX Oct 29, 2020 4.11 +1.86   
 Castellum CAST Oct 29, 2020 185.45 +0.57   
 Catella A CATA Oct 29, 2020 21.40 +1.90   
 Catella B CATB Oct 29, 2020 19.75 +0.51   
 Catena CATE Oct 29, 2020 364.00 +2.54   
 Catena Media CTM Oct 29, 2020 29.86 -2.10   
 Cavotec SA CCC Oct 29, 2020 19.25 -0.52   
 Cell Impact B CIB Oct 29, 2020 22.00 +3.04   
 CellaVision CEVI Oct 29, 2020 270.00 -2.10   
 CELLINK B CLNKB Oct 29, 2020 175.00 -4.89   
 Cereno Scientific B CRNOB Oct 29, 2020 1.82 +4.12   
 CGit B CGITB Oct 29, 2020 34.00 +5.59   
 Challenger Mobile B CHALB Oct 29, 2020 0.14 +12.10   
 Chordate Medical Holding CMH Oct 29, 2020 0.45 -7.41   
 Christian Berner Tech Trade B CBTTB Oct 29, 2020 22.00 -1.79   
 ChromoGenics CHRO Oct 29, 2020 14.00 -4.76   
 Cibus Nordic Real Estate CIBUS Oct 29, 2020 148.80 -0.27   
 Clas Ohlson B CLASB Oct 29, 2020 78.80 -0.44   
 Clavister Holding CLAV Oct 29, 2020 7.30 -0.82   
 Clean Motion CLEMO Oct 29, 2020 1.02 -5.12   
 Clemondo Group CLEM Oct 29, 2020 3.92 +5.38   
 Climeon B CLIMEB Oct 29, 2020 42.78 +1.91   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK